With ongoing shifts in the pharmacy landscape, drug-level rebate models are likely to gain broader adoption in pharmacy benefit contracts, making it essential for employers and brokers to understand their structure and impact.
Join Truveris experts for a focused discussion on the fundamentals of drug-level rebate models, how these models could reshape PBM contract structures, and the factors plan sponsors should consider when assessing these models.
We’ll examine metrics, financial considerations, and contract provisions most likely to be affected, providing practical guidance on how to evaluate these evolving rebate models, and what to watch for as these models become more prevalent.
Learning Objectives
- Understand what drug-level rebates are and how they compare to other rebate models: Examine how drug-level rebate models may change the way rebates are structured and passed through to employers.
- See how to evaluate drug-level rebate offers: Learn practical approaches for assessing drug-level rebate structures and how they may affect rebate expectations based on contract terms and utilization.
About the Speaker:
Kian Bichoupan, PhD, Chief Strategy Officer
Kian brings more than a decade of experience across the pharmacy and healthcare industry, spanning both pharmaceutical manufacturers and pharmacy benefit management. He specializes in procurement and service monitoring for employer plan sponsors and is also a prolific researcher, with more than 50 publications and presentations on healthcare economics, drug pricing, and real-world evidence, primarily focused on infectious diseases.
Rachel Ramras – Vice President, Product Strategy
Rachel has spent more than a decade helping employers navigate the complexities of pharmacy benefits. Drawing on a deep understanding of pharmacy procurement, market trends, pricing dynamics and plan sponsor needs, Rachel works to ensure Truveris’ products remain responsive to an evolving pharmacy landscape. With a background in economics and mathematics, Rachel brings a uniquely analytical perspective to product development, market strategy, and improving outcomes for healthcare stakeholders.
Truveris is a pharmacy cost containment company dedicated to reducing pharmacy costs and driving transparency for employers and benefit consultants. Our proprietary, data-driven technology and deep industry expertise empower smarter pharmacy benefit decisions through contract optimization and PBM oversight. Independent and unbiased, Truveris delivers measurable savings and accountability across every pharmacy program.
